Aurora Cannabis (TSE:ACB) Stock Price Down 8.7% – Time to Sell?

Aurora Cannabis Inc. (TSE:ACBGet Free Report)’s stock price traded down 8.7% during trading on Thursday . The stock traded as low as C$3.77 and last traded at C$4.19. 1,244,707 shares changed hands during trading, an increase of 205% from the average session volume of 408,107 shares. The stock had previously closed at C$4.59.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the stock. TD decreased their target price on shares of Aurora Cannabis to C$8.00 and set a “buy” rating for the company in a research note on Friday. Canaccord Genuity Group dropped their price target on Aurora Cannabis from C$8.00 to C$6.50 and set a “buy” rating on the stock in a research report on Friday. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat, Aurora Cannabis has an average rating of “Buy” and an average price target of C$7.67.

Check Out Our Latest Stock Analysis on Aurora Cannabis

Aurora Cannabis Trading Down 0.7%

The stock’s 50 day moving average is C$4.76 and its 200-day moving average is C$5.30. The company has a market cap of C$251.29 million, a P/E ratio of -2.83 and a beta of 0.17. The company has a current ratio of 5.94, a quick ratio of 2.48 and a debt-to-equity ratio of 4.66.

Aurora Cannabis (TSE:ACBGet Free Report) last released its quarterly earnings data on Thursday, June 11th. The company reported C($0.99) earnings per share for the quarter. The firm had revenue of C$38.01 million for the quarter. Aurora Cannabis had a negative net margin of 12.13% and a negative return on equity of 7.25%. Research analysts anticipate that Aurora Cannabis Inc. will post -0.22 earnings per share for the current fiscal year.

Aurora Cannabis Company Profile

(Get Free Report)

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

Recommended Stories

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.